OtoID: New extended frequency, portable audiometer for ototoxicity monitoring

Journal of Rehabilitation Research and Development

Volumn 50, Issue 7, 2013, Pages 997-1006

  Dille, Marilyn F ^a,b   Jacobs, Peter G ^a,b,c   Gordon, Samuel Y ^a   Helt, Wendy J ^a   McMillan, Garnett P ^a,d  

^a NATIONAL CENTER FOR REHABILITATIVE AUDITORY RESEARCH   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c Oregon Health and Science University Department of Biomedical Engineering   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Audiometer; Chemotherapy; Cisplatin; Hearing loss; Monitoring; OtoID; Ototoxicity; Rehabilitation; Tinnitus; Veterans

Indexed keywords

CIS-PLATIN; HEARING LOSS; OTOID; OTOTOXICITY; TINNITUS; VETERANS;

AUDIOMETERS; CHEMOTHERAPY; HOSPITALS; MONITORING; PATIENT REHABILITATION; PATIENT TREATMENT; PLATINUM COMPOUNDS; TESTING;

AUDITION;

ADULT; AGED; ARTICLE; AUDIOLOGIST; AUDIOMETER; AUTOMATION; CLINICAL ARTICLE; COMPUTER PROGRAM; ELECTRICAL EQUIPMENT; FALSE POSITIVE RESULT; FEMALE; HEADPHONE; HEARING IMPAIRMENT; HEARING TEST; HUMAN; MALE; MEDICAL SOCIETY; MICROPROCESSOR; OTOTOXICITY; PORTABLE EQUIPMENT; PRIORITY JOURNAL; REPRODUCIBILITY; SELF EXAMINATION; VALIDATION PROCESS; WARD;

AUDIOMETER; CHEMOTHERAPY; CISPLATIN; HEARING LOSS; MONITORING; OTOID; OTOTOXICITY; REHABILITATION; TINNITUS; VETERANS;

ADOLESCENT; ADULT; AGED; AUDIOMETRY, PURE-TONE; AUDITORY THRESHOLD; AUTOMATION; DIAGNOSTIC SELF EVALUATION; FALSE POSITIVE REACTIONS; FEMALE; HEARING LOSS; HUMANS; MALE; MIDDLE AGED; POINT-OF-CARE SYSTEMS; REPRODUCIBILITY OF RESULTS; YOUNG ADULT;

EID: 84887300393     PISSN: 07487711     EISSN: 19381352     Source Type: Journal    
DOI: 10.1682/JRRD.2012.09.0176     Document Type: Article

References (11)

1. Fausti SA, Larson VD, Noffsinger D, Wilson RH, Phillips DS, Fowler CG. High-frequency audiometric monitoring strategies for early detection of ototoxicity. Ear Hear. 1994; 15(3):232-39. [PMID:8076721] http://dx.doi.org/10.1097/00003446-199406000-00004
2. Fausti SA, Henry JA, Helt WJ, Phillips DS, Frey RH, Noffsinger D, Larson VD, Fowler CG. An individualized, sensitive frequency range for early detection of ototoxicity. Ear Hear. 1999;20(6):497-505. [PMID:10613387] http://dx.doi.org/10.1097/00003446-199912000-00005
3. de Jongh FE, van Veen RN, Veltman SJ, de Wit R, van der Burg ME, van den Bent MJ, Planting AS, Graveland WJ, Stoter G, Verweij J. Weekly high-dose cisplatin is a feasible treatment option: Analysis on prognostic factors for toxicity in 400 patients. Br J Cancer. 2003;88(8):1199-1206. [PMID:12698184] http://dx.doi.org/10.1038/sj.bjc.6600884
4. Reavis KM, McMillan G, Austin D, Gallun F, Fausti SA, Gordon JS, Helt WJ, Konrad-Martin D. Distortion-product otoacoustic emission test performance for ototoxicity monitoring. Ear Hear. 2011;32(1):61-74. [PMID:20625302]
5. Dille MF, Konrad-Martin D, Gallun FJ, Helt WJ, Gordon JS, Reavis KM, Bratt GW, Fausti SA. Tinnitus onset rates from chemotherapeutic agents and ototoxic antibiotics: Results of a large prospective study. J Am Acad Audiol. 2010;21(6): 409-17. [PMID:20701838] http://dx.doi.org/10.3766/jaaa.21.6.6
6. Dille MF, Wilmington D, McMillan GP, Helt W, Fausti SA, Konrad-Martin D. Development and validation of a cisplatin dose-ototoxicity model. J Am Acad Audiol. 2012;23(7): 510-21. [PMID:22992258] http://dx.doi.org/10.3766/jaaa.23.7.3
7. Reavis KM, Phillips DS, Fausti SA, Gordon JS, Helt WJ, Wilmington D, Bratt GW, Konrad-Martin D. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss. Ear Hear. 2008;29(6):875-93. [PMID:18753950] http://dx.doi.org/10.1097/AUD.0b013e318181ad99
8. Jacobs PG, Silaski G, Wilmington D, Gordon S, Helt W, McMillan G, Fausti SA, Dille MF. Development and evaluation of a portable audiometer for high-frequency screening of hearing loss from ototoxicity in homes/clinics. IEEE Trans Biomed Eng. 2012;59(11):3097-3103. [PMID:22801480] http://dx.doi.org/10.1109/TBME.2012.2204881
9. Carhart R, Jerger J. Preferred method for clinical determination of pure-tone thresholds. J Speech Hear Dis. 1959; 24:330-45.
10. Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res. 1999;8(2): 135-60.[PMID:10501650] http://dx.doi.org/10.1191/096228099673819272
11. American Speech-Language-Hearing Association. Audiologic management of individuals receiving cochleotoxic drug therapy [Internet]. American Speech-Language-Hearing Association: 1994 [cited 2012 Sep 15]. Available from: www.asha.org/policy